QBCLINIC
LIVE

Serial Number

98722636

Owner

Qbtech AB

Attorney

Maurine Knutsson

Filing Date

Aug 28, 2024

Add to watchlist:

No watchlists yet
View on USPTO

QBCLINIC Trademark

Serial Number: 98722636 • Registration: 8082453

QBCLINIC is a trademark filed by Qbtech AB on August 28, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Qbtech AB (8 trademarks)

Cardellgatan 1

Entity Type: 98

Trademark Details

Filing Date

August 28, 2024

Registration Date

December 30, 2025

Published for Opposition

November 11, 2025

Goods & Services

data processing equipment; downloadable and recorded computer programs for medical diagnosis of behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD) and the collection of test results used in determining the existence, type, and extent of behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD) for patient assessment; recorded computer programs in the field of medical diagnostics and for the purpose of collection of test results for patient assessment; downloadable computer programs in the field of medical diagnostics and for the purpose of collection of test results for patient assessment; downloadable computer programs, including for medical diagnostics and the collection of test results for patient assessment, namely, Software as a Medical Device (SaMD), downloadable, for diagnosing and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD)

consultancy services relating to medicine and healthcare; computer-supported services within medical diagnostics and patients assessment, namely, medical assistance services in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of archived medical images, documents, and data and a data storage and retrieval system, all relating to medical diagnostics and patient assessment; medical consultations provided online via chat, e-mail, telephone service over the internet, and video conference; consulting services in the fields of clinical testing; medical services being medical testing services; medical services being medical testing for diagnostic or treatment purposes; medical services being clinical testing in the field of behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD)

business administration relating to medical diagnostics; compiling statistical business data and patient assessment; business administration in the field of medical diagnostics ; business administration in the field of medical diagnosis of behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD)

development of test methods for use in the diagnosing, monitoring, examining, and treating behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); Development and establishment of testing specifications and procedures in the field of behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); scientific and technological services, namely, medical and scientific research in the field of behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); technological services, design and development of computer software for use in the diagnosing, monitoring, examining, and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); analytical services relating to computer programs and patient data, namely, analysis of patient data on computer systems relating to diagnosing, monitoring, examining, and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); computer systems analysis, namely, analysis of patient data on computer systems; medical services being medical research; Scientific research in the nature of conducting clinical trials for others; providing a website featuring information in the field of investigational medical diagnostics related to behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); scientific and technological services, namely, scientific research, analysis and testing in the field of behavioral and neurological disorders; computer system analysis; medical research in the field of behavioral and neurological disorders; medical and scientific research, namely, conducting clinical trials for others; compiling data for research purposes in the field of medical science and medical consultancy; consulting services in the field of medical research; consulting services in the fields of medical research; providing temporary use of non-downloadable computer programs for medical diagnosis of behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD) and the collection of test results used in determining the existence, type, and extent of behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD) for patient assessment; providing temporary use of non-downloadable computer programs, including for medical diagnostics and the collection of test results for patient assessment, namely, Software as a Service (SaaS) services featuring software for diagnosing and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); technological services, namely, Software as a Service (SaaS) services featuring software for diagnosing and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); technological services, namely, Software as a Service (SAAS) services featuring software for collection of test results for patient assessment in the field of medical diagnostics; technological services, namely, Software as a service (SAAS) services featuring software for use in the diagnosing, monitoring, examining, and treating behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); technological services, namely, Software as a service (SAAS) services featuring software for accessing, managing, importing, exporting, securing, and acquiring patient data relating to diagnosing, monitoring, examining, and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); technological services, namely, Platform as a service (PAAS) services featuring software platforms for diagnosing and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); technological services, namely, Platform as a service (PAAS) services featuring software platforms for collection of test results for patient assessment in the field of medical diagnostics; technological services, namely, Platform as a service (PAAS) services featuring software platforms for use in the diagnosing, monitoring, examining, and treating behavior disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); technological services, namely, Platform as a service (PAAS) services featuring software platforms for accessing, managing, importing, exporting, securing, and acquiring patient data relating to diagnosing, monitoring, examining, and treating behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); computer-supported services within medical diagnostics and patients assessment, namely, proving online non-downloadable computer software platforms for diagnosing and assessing patients in the field of behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); computer-supported services within medical diagnostics and patients assessment, namely, Software as a Service (SaaS) services featuring software for diagnosing and assessing behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD); computer-supported services within medical diagnostics and patients assessment, namely, Software as a Service (SAAS) services featuring software for collection of test results for patient assessment in the field of medical diagnostics; medical consultations provided online, namely, providing online non-downloadable computer software platforms for providing online medical consultations in the field of behavioral disorders, neurodevelopmental disorders, Attention Deficit Disorder (ADD), and Attention Deficit Hyperactivity Disorder (ADHD)

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 30, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 30, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 9, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 11, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 5, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 5, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 12, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 12, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 12, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 4, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2025 NWOS
NEW APPLICATION ENTERED
Aug 28, 2024 NWAP